Clinical trial
Aripiprazole in At-Risk Children With Symptoms of Bipolar Disorder
NCT00194012 is registered in ClinicalTrials.gov with University Hospitals Cleveland Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aripiprazole in At-Risk Children With Symptoms of Bipolar Disorder
- Lead sponsor
- University Hospitals Cleveland Medical Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2004
- Completion date
- June 30, 2012
- Enrollment
- 62 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.